https://news.medxy.ai/zh/%e4%bc%98%e5%8c%96%e7%ac%ac%e4%ba%8c%e4%ba%a7%e7%a8%8b%ef%bc%9a%e5%88%86%e5%a8%a9%e6%ac%a1%e6%95%b0%e3%80%81%e8%83%8e%e5%84%bf%e4%bd%8d%e7%bd%ae%e5%92%8c%e7%a1%ac%e8%86%9c%e5%a4%96%e9%95%87%e7%97%9b/Medxy AIzh2026-05-13T13:54:35-07:00优化第二产程：分娩次数、胎儿位置和硬膜外镇痛对自然分娩成功的影响 https://news.medxy.ai/ja/%e5%88%86%e5%a8%a9%e7%ac%ac%e4%ba%8c%e4%ba%a7%e7%a8%8b%e7%9a%84%e4%bc%98%e5%8c%96%ef%bc%9a%e4%ba%a7%e6%ac%a1%e3%80%81%e8%83%8e%e4%bd%8d%e5%92%8c%e7%a1%ac%e8%86%9c%e5%a4%96%e9%ba%bb%e9%86%89%e5%af%b9/Medxy AIja2026-05-13T13:53:28-07:00分娩第二产程的优化：产次、胎位和硬膜外麻醉对自然分娩成功的影响 https://news.medxy.ai/vi/toi-uu-hoa-giai-doan-thu-hai-cua-chuyen-da-tuong-tac-giua-so-lan-sinh-vi-tri-thai-va-gay-te-tuy-song-doi-voi-thanh-cong-cua-sinh-tu-nhien/Medxy AIvi2026-05-13T13:52:23-07:00Tối ưu hóa giai đoạn thứ hai của chuyển dạ: Tương tác giữa số lần sinh, vị trí thai và gây tê tủy sống đối với thành công của sinh tự nhiên https://news.medxy.ai/optimizing-the-second-stage-of-labor-the-interplay-of-parity-fetal-position-and-epidural-analgesia-on-spontaneous-delivery-success/Medxy AIen2026-05-13T13:49:50-07:00Optimizing the Second Stage of Labor: The Interplay of Parity, Fetal Position, and Epidural Analgesia on Spontaneous Delivery Success https://news.medxy.ai/vi/sau-gio-co-the-du-cho-viec-nen-bong-tu-cung-sau-xuat-huyet-sau-sinh/Medxy AIvi2026-05-13T13:34:27-07:00Sáu giờ có thể đủ cho việc nén bóng tử cung sau xuất huyết sau sinh https://news.medxy.ai/ja/%e7%94%a3%e5%be%8c%e5%87%ba%e8%a1%80%e5%be%8c%e3%81%ae%e5%ad%90%e5%ae%ae%e5%86%85%e3%83%90%e3%83%ab%e3%83%bc%e3%83%b3%e5%9c%a7%e8%bf%ab%e3%81%ab%e3%81%a4%e3%81%84%e3%81%a6%e3%80%816%e6%99%82%e9%96%93/Medxy AIja2026-05-13T13:32:51-07:00産後出血後の子宮内バルーン圧迫について、6時間で十分な可能性 https://news.medxy.ai/zh/%e4%ba%a7%e5%90%8e%e5%87%ba%e8%a1%80%e5%90%8e%e5%ae%ab%e5%86%85%e7%90%83%e5%9b%8a%e5%8e%8b%e8%bf%ab6%e5%b0%8f%e6%97%b6%e5%8f%af%e8%83%bd%e8%b6%b3%e5%a4%9f/Medxy AIzh2026-05-13T13:31:24-07:00产后出血后宫内球囊压迫6小时可能足够 https://news.medxy.ai/six-hours-may-be-enough-for-intrauterine-balloon-tamponade-after-postpartum-hemorrhage/Medxy AIen2026-05-13T13:29:36-07:00Six Hours May Be Enough for Intrauterine Balloon Tamponade After Postpartum Hemorrhage https://news.medxy.ai/vi/chup-mri-ngan-gon-khong-can-chat-doi-quang-cho-thay-do-chinh-xac-vuot-troi-hon-so-voi-sieu-am-trong-viec-theo-doi-ung-thu-te-bao-gan-o-benh-nhan-xo-gan-ket-qua-thu-nghiem-tien-cuu-giai-doan/Medxy AIvi2026-05-13T13:21:07-07:00Chụp MRI ngắn gọn không cần chất đối quang cho thấy độ chính xác vượt trội hơn so với siêu âm trong việc theo dõi ung thư tế bào gan ở bệnh nhân xơ gan: Kết quả thử nghiệm tiền cứu giai đoạn https://news.medxy.ai/ja/%e9%9d%9e%e9%80%a0%e5%bd%b1%e7%b0%a1%e7%95%a5mri%e5%9c%a8%e8%82%9d%e7%a1%ac%e5%8c%96%e6%82%a3%e8%80%85%e7%9a%84%e8%82%9d%e7%b4%b0%e8%83%9e%e7%99%8c%e7%9b%a3%e8%a6%96%e4%b8%ad%e9%a1%af%e7%a4%ba/Medxy AIja2026-05-13T13:19:46-07:00非造影簡略MRI在肝硬化患者的肝細胞癌監視中顯示出比超聲波更優異的準確性：前瞻性試驗的中期結果 https://news.medxy.ai/zh/%e6%97%a0%e5%af%b9%e6%af%94%e5%89%82%e7%ae%80%e5%8c%96mri%e5%9c%a8%e8%82%9d%e7%a1%ac%e5%8c%96%e6%82%a3%e8%80%85%e4%b8%ad%e5%af%b9%e8%82%9d%e7%bb%86%e8%83%9e%e7%99%8c%e7%9b%91%e6%b5%8b%e7%9a%84/Medxy AIzh2026-05-13T13:18:45-07:00无对比剂简化MRI在肝硬化患者中对肝细胞癌监测的准确性优于超声：前瞻性试验中期结果 https://news.medxy.ai/non-contrast-abbreviated-mri-shows-superior-accuracy-to-ultrasound-for-hepatocellular-carcinoma-surveillance-in-cirrhosis-interim-prospective-trial-results/Medxy AIen2026-05-13T13:17:15-07:00Non-contrast abbreviated MRI shows superior accuracy to ultrasound for hepatocellular carcinoma surveillance in cirrhosis: interim prospective trial results https://news.medxy.ai/vi/thu-nghiem-kiem-soat-gia-mao-cho-thay-dieu-chinh-than-kinh-qua-lung-co-the-giam-tieu-khong-tu-chu/Medxy AIvi2026-05-13T13:00:55-07:00Thử nghiệm kiểm soát giả mạo cho thấy điều chỉnh thần kinh qua lưng có thể giảm tiểu không tự chủ https://news.medxy.ai/ja/%e5%81%bd%e5%88%b6%e5%be%a1%e8%a9%a6%e9%a8%93%e3%81%a7%e3%80%81%e8%85%b0%e4%bb%99%e9%aa%a8%e7%a5%9e%e7%b5%8c%e8%aa%bf%e7%af%80%e3%81%8c%e4%be%bf%e5%a4%b1%e7%a6%81%e3%82%92%e8%bb%bd%e6%b8%9b%e3%81%99/Medxy AIja2026-05-13T12:59:09-07:00偽制御試験で、腰仙骨神経調節が便失禁を軽減する可能性が示唆 https://news.medxy.ai/zh/%e5%af%b9%e7%85%a7%e8%af%95%e9%aa%8c%e5%8f%91%e7%8e%b0%e7%bb%8f%e8%85%b0%e9%aa%b6%e7%a5%9e%e7%bb%8f%e8%b0%83%e8%8a%82%e5%8f%af%e8%83%bd%e5%87%8f%e5%b0%91%e5%a4%a7%e4%be%bf%e5%a4%b1%e7%a6%81/Medxy AIzh2026-05-13T12:57:31-07:00对照试验发现经腰骶神经调节可能减少大便失禁 https://news.medxy.ai/sham-controlled-trial-finds-translumbosacral-neuromodulation-may-reduce-fecal-incontinence/Medxy AIen2026-05-13T12:55:41-07:00Sham-Controlled Trial Finds Translumbosacral Neuromodulation May Reduce Fecal Incontinence https://news.medxy.ai/ja/%e7%a1%ac%e8%86%9c%e5%8b%95%e9%9d%99%e8%84%88%e7%98%bb%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e5%85%a8%e8%ba%ab%e5%bf%83%e8%a1%80%e7%ae%a1%e8%a6%81%e5%9b%a0%e3%81%a8%e4%ba%88%e5%be%8c%ef%bc%9acondor/Medxy AIja2026-05-13T12:44:36-07:00硬膜動静脈瘻における全身心血管要因と予後：CONDORレジストリからの知見 https://news.medxy.ai/vi/cac-yeu-to-tim-mach-toan-than-va-ket-qua-trong-u-dong-tinh-mach-mang-cung-nhung-hieu-biet-tu-dang-ky-condor/Medxy AIvi2026-05-13T12:42:48-07:00Các yếu tố tim mạch toàn thân và kết quả trong u động tĩnh mạch màng cứng: Những hiểu biết từ Đăng ký CONDOR https://news.medxy.ai/systemic-cardiovascular-factors-and-outcomes-in-dural-arteriovenous-fistulas-insights-from-the-condor-registry/Medxy AIen2026-05-13T12:39:11-07:00Systemic Cardiovascular Factors and Outcomes in Dural Arteriovenous Fistulas: Insights From the CONDOR Registry https://news.medxy.ai/ja/%e8%84%b3%e3%81%ae%e3%80%8c%e6%b1%9a%e3%82%8c%e3%81%9f%e3%80%8d%e7%99%bd%e8%b3%aa%e3%81%a8%e8%aa%8d%e7%9f%a5%e6%a9%9f%e8%83%bd%e4%bd%8e%e4%b8%8b%e3%81%8a%e3%82%88%e3%81%b3%e8%aa%8d%e7%9f%a5%e7%97%87/Medxy AIja2026-05-13T11:47:27-07:00脳の「汚れた」白質と認知機能低下および認知症リスクとの関連 https://news.medxy.ai/vi/chat-trang-nao-ban-va-moi-lien-he-voi-suy-giam-nhan-thuc-va-nguy-co-sa-sut-tri-tue/Medxy AIvi2026-05-13T11:45:31-07:00Chất trắng não ‘bẩn’ và mối liên hệ với suy giảm nhận thức và nguy cơ sa sút trí tuệ https://news.medxy.ai/cerebral-dirty-appearing-white-matter-and-its-link-to-cognitive-decline-and-dementia-risk/Medxy AIen2026-05-13T11:42:35-07:00Cerebral “Dirty-Appearing” White Matter and Its Link to Cognitive Decline and Dementia Risk https://news.medxy.ai/vi/ngung-dieu-tri-o-benh-nhan-mac-benh-lien-quan-den-khang-the-protein-glycoprotein-oligodendrocyte-myelin/Medxy AIvi2026-05-13T11:35:30-07:00Ngừng điều trị ở bệnh nhân mắc bệnh liên quan đến kháng thể protein glycoprotein oligodendrocyte myelin https://news.medxy.ai/zh/distal-12%e4%b8%aa%e6%9c%88%e7%bb%93%e6%9e%9c%ef%bc%9a%e4%b8%ad%e8%bf%9c%e7%ab%af%e8%a1%80%e7%ae%a1%e9%97%ad%e5%a1%9e%e6%80%a7%e5%8d%92%e4%b8%ad%e7%9a%84%e8%a1%80%e7%ae%a1%e5%86%85%e6%b2%bb%e7%96%97/Medxy AIzh2026-05-13T11:34:03-07:00DISTAL 12个月结果：中远端血管闭塞性卒中的血管内治疗在功能和生存方面无优势 https://news.medxy.ai/ja/%e6%8a%97%e3%83%9f%e3%82%a8%e3%83%aa%e3%83%b3%e3%82%aa%e3%83%aa%e3%82%b4%e3%83%87%e3%83%b3%e3%83%89%e3%83%ad%e3%82%b5%e3%82%a4%e3%83%88%e3%82%b0%e3%83%aa%e3%82%b3%e3%83%97%e3%83%ad%e3%83%86%e3%82%a4/Medxy AIja2026-05-13T11:33:56-07:00抗ミエリンオリゴデンドロサイトグリコプロテイン抗体関連疾患の患者における治療中止 https://news.medxy.ai/zh/%e6%8a%97%e9%ab%93%e9%9e%98%e5%b0%91%e7%aa%81%e8%83%b6%e8%b4%a8%e7%bb%86%e8%83%9e%e7%b3%96%e8%9b%8b%e7%99%bd%e6%8a%97%e4%bd%93%e7%9b%b8%e5%85%b3%e7%96%be%e7%97%85%e7%9a%84%e6%b2%bb%e7%96%97%e5%81%9c/Medxy AIzh2026-05-13T11:32:30-07:00抗髓鞘少突胶质细胞糖蛋白抗体相关疾病的治疗停药 https://news.medxy.ai/ja/distal-12%e3%83%b6%e6%9c%88-%e8%bb%bd%e5%ba%a6%e3%81%8b%e3%82%89%e4%b8%ad%e7%ad%89%e5%ba%a6%e3%81%ae%e4%b8%ad%e3%81%be%e3%81%9f%e3%81%af%e9%81%a0%e4%bd%8d%e8%a1%80%e7%ae%a1%e9%96%89%e5%a1%9e%e8%84%b3/Medxy AIja2026-05-13T11:31:31-07:00DISTAL 12ヶ月: 軽度から中等度の中または遠位血管閉塞脳卒中に対する経皮的血管内治療の機能的・生存上の優位性なし https://news.medxy.ai/treatment-discontinuation-in-patients-with-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/Medxy AIen2026-05-13T11:31:00-07:00Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease https://news.medxy.ai/vi/distal-sau-12-thang-khong-co-loi-the-chuc-nang-hoac-song-sot-cho-dieu-tri-noi-mach-trong-dot-quy-tac-mach-trung-binh-hoac-xa-muc-nhe-den-trung-binh/Medxy AIvi2026-05-13T11:28:06-07:00DISTAL sau 12 tháng: Không có lợi thế chức năng hoặc sống sót cho điều trị nội mạch trong đột quỵ tắc mạch trung bình hoặc xa mức nhẹ đến trung bình https://news.medxy.ai/distal-at-12-months-no-functional-or-survival-advantage-for-endovascular-therapy-in-mild-to-moderate-medium-or-distal-vessel-occlusion-stroke/Medxy AIen2026-05-13T11:22:04-07:00DISTAL at 12 Months: No Functional or Survival Advantage for Endovascular Therapy in Mild-to-Moderate Medium or Distal Vessel Occlusion Stroke https://news.medxy.ai/ja/%e3%83%88%e3%82%b7%e3%83%aa%e3%82%ba%e3%83%9e%e3%83%96%e3%80%81%e7%b3%96%e7%9a%ae%e8%b3%aa%e3%83%9b%e3%83%ab%e3%83%a2%e3%83%b3%e6%8a%b5%e6%8a%97%e6%80%a7%e7%94%b2%e7%8a%b6%e8%85%ba%e7%9c%bc%e7%97%87/Medxy AIja2026-05-13T11:13:08-07:00トシリズマブ、糖皮質ホルモン抵抗性甲状腺眼症で有望な効果を示す https://news.medxy.ai/vi/tocilizumab-hien-thi-nhung-loi-ich-hua-hen-trong-benh-mat-giap-chong-choi-voi-glucocorticoid/Medxy AIvi2026-05-13T11:11:41-07:00Tocilizumab Hiển Thị Những Lợi Ích Hứa Hẹn trong Bệnh Mắt Giáp Chống Chọi với Glucocorticoid https://news.medxy.ai/tocilizumab-shows-promising-benefits-in-glucocorticoid-resistant-thyroid-eye-disease/Medxy AIen2026-05-13T11:08:26-07:00Tocilizumab Shows Promising Benefits in Glucocorticoid-Resistant Thyroid Eye Disease https://news.medxy.ai/vi/phan-loai-tang-duong-huyet-trung-gian-de-cai-thien-phong-ngua-benh-tieu-duong-loai-2-ket-qua-tu-nghien-cuu-elsa-brasil/Medxy AIvi2026-05-13T10:57:17-07:00Phân loại tăng đường huyết trung gian để cải thiện phòng ngừa bệnh tiểu đường loại 2: Kết quả từ nghiên cứu ELSA-Brasil https://news.medxy.ai/ja/%e4%b8%ad%e9%96%93%e9%ab%98%e8%a1%80%e7%b3%96%e3%81%ae%e6%ae%b5%e9%9a%8e%e5%8c%96%e3%81%ab%e3%82%88%e3%82%8b2%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e4%ba%88%e9%98%b2%e3%81%ae%e6%94%b9%e5%96%84%ef%bc%9ae/Medxy AIja2026-05-13T10:55:28-07:00中間高血糖の段階化による2型糖尿病予防の改善：ELSA-Brasil研究の結果 https://news.medxy.ai/zh/%e5%88%86%e6%9c%9f%e4%b8%ad%e5%ba%a6%e9%ab%98%e8%a1%80%e7%b3%96%e4%bb%a5%e6%94%b9%e5%96%842%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e9%a2%84%e9%98%b2%ef%bc%9a%e6%9d%a5%e8%87%aaelsa-brasil%e7%a0%94/Medxy AIzh2026-05-13T10:53:40-07:00分期中度高血糖以改善2型糖尿病预防：来自ELSA-Brasil研究的结果 https://news.medxy.ai/staging-intermediate-hyperglycaemia-to-improve-type-2-diabetes-prevention-findings-from-the-elsa-brasil-study/Medxy AIen2026-05-13T10:50:55-07:00Staging Intermediate Hyperglycaemia to Improve Type 2 Diabetes Prevention: Findings from the ELSA-Brasil Study https://news.medxy.ai/most-bilateral-adrenal-lesions-are-benign-and-concordant-but-asynchronous-presentation-signals-higher-malignancy-risk/Medxy AIen2026-05-13T10:32:48-07:00Most Bilateral Adrenal Lesions Are Benign and Concordant, but Asynchronous Presentation Signals Higher Malignancy Risk https://news.medxy.ai/vi/viec-tang-can-tro-lai-co-the-dao-nguoc-loi-ich-chuyen-hoa-cua-viec-han-che-calo-nhung-hieu-biet-tu-calerie-2/Medxy AIvi2026-05-13T10:13:40-07:00Việc tăng cân trở lại có thể đảo ngược lợi ích chuyển hóa của việc hạn chế calo: Những hiểu biết từ CALERIE-2 https://news.medxy.ai/ja/%e4%bd%93%e9%87%8d%e5%9b%9e%e5%8d%87%e5%8f%af%e9%80%86%e8%bd%ac%e7%83%ad%e9%87%8f%e9%99%90%e5%88%b6%e7%9a%84%e4%bb%a3%e8%b0%a2%e7%9b%8a%e5%a4%84%ef%bc%9a%e6%9d%a5%e8%87%aacalerie-2%e7%9a%84%e8%a7%81/Medxy AIja2026-05-13T10:11:40-07:00体重回升可逆转热量限制的代谢益处：来自CALERIE-2的见解 https://news.medxy.ai/zh/%e4%bd%93%e9%87%8d%e5%9b%9e%e5%8d%87%e5%8f%af%e9%80%86%e8%bd%ac%e7%83%ad%e9%87%8f%e9%99%90%e5%88%b6%e5%b8%a6%e6%9d%a5%e7%9a%84%e4%bb%a3%e8%b0%a2%e7%9b%8a%e5%a4%84%ef%bc%9a%e6%9d%a5%e8%87%aacalerie-2/Medxy AIzh2026-05-13T10:10:36-07:00体重回升可逆转热量限制带来的代谢益处：来自CALERIE-2的见解 https://news.medxy.ai/weight-regain-can-reverse-the-metabolic-benefits-of-caloric-restriction-insights-from-calerie-2/Medxy AIen2026-05-13T10:08:12-07:00Weight Regain Can Reverse the Metabolic Benefits of Caloric Restriction: Insights From CALERIE-2 https://news.medxy.ai/ja/tirzepatide%e5%af%bedulaglutide%ef%bc%9a2%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%85%8e%e8%87%93%e3%82%a2%e3%82%a6%e3%83%88%e3%82%ab%e3%83%a0%e3%81%aesurpass-cvot/Medxy AIja2026-05-12T16:41:49-07:00Tirzepatide対Dulaglutide：2型糖尿病における腎臓アウトカムのSURPASS-CVOT https://news.medxy.ai/vi/tirzepatide-so-voi-dulaglutide-ket-qua-ve-than-o-benh-nhan-tieu-duong-tuyp-2-tu-surpass-cvot/Medxy AIvi2026-05-12T16:40:03-07:00Tirzepatide so với Dulaglutide: Kết quả về thận ở bệnh nhân tiểu đường tuýp 2 từ SURPASS-CVOT https://news.medxy.ai/tirzepatide-vs-dulaglutide-kidney-outcomes-in-type-2-diabetes-from-surpass-cvot/Medxy AIen2026-05-12T16:37:40-07:00Tirzepatide vs dulaglutide: kidney outcomes in type 2 diabetes from SURPASS-CVOT https://news.medxy.ai/cardiomyopathy-gene-therapy-reaches-an-inflection-point-from-aav-delivery-to-precision-genome-editing/Medxy AIen2026-05-12T16:32:48-07:00Cardiomyopathy Gene Therapy Reaches an Inflection Point: From AAV Delivery to Precision Genome Editing https://news.medxy.ai/vi/ket-qua-thay-the-van-ba-la-dua-tren-muc-do-nang-cua-trao-nguoc-van-ba-la-thu-nghiem-triscend-ii/Medxy AIvi2026-05-12T16:32:39-07:00Kết quả thay thế van ba lá dựa trên mức độ nặng của trào ngược van ba lá: Thử nghiệm TRISCEND II https://news.medxy.ai/ja/%e5%9f%ba%e7%b7%9a%e4%b8%89%e5%b0%96%e7%93%a3%e9%80%86%e6%b5%81%e3%81%ae%e9%87%8d%e7%97%87%e5%ba%a6%e3%81%ab%e3%82%88%e3%82%8b%e4%b8%89%e5%b0%96%e7%93%a3%e7%bd%ae%e6%8f%9b%e8%a1%93%e3%81%ae%e7%b5%90/Medxy AIja2026-05-12T16:30:55-07:00基線三尖瓣逆流の重症度による三尖瓣置換術の結果：TRISCEND II試験 https://news.medxy.ai/zh/%e4%b8%89%e5%b0%96%e7%93%a3%e7%bd%ae%e6%8d%a2%e6%9c%af%e5%af%b9%e5%9f%ba%e7%ba%bf%e4%b8%89%e5%b0%96%e7%93%a3%e5%8f%8d%e6%b5%81%e4%b8%a5%e9%87%8d%e7%a8%8b%e5%ba%a6%e7%9a%84%e7%bb%93%e6%9e%9c%ef%bc%9atr/Medxy AIzh2026-05-12T16:29:21-07:00三尖瓣置换术对基线三尖瓣反流严重程度的结果：TRISCEND II试验 https://news.medxy.ai/tricuspid-valve-replacement-outcomes-by-baseline-tricuspid-regurgitation-severity-triscend-ii-trial/Medxy AIen2026-05-12T16:27:37-07:00Tricuspid Valve Replacement Outcomes by Baseline Tricuspid Regurgitation Severity: TRISCEND II Trial https://news.medxy.ai/why-the-ctni-ctnt-ratio-may-matter-a-new-signal-for-distinguishing-acute-necrotic-from-chronic-myocardial-injury/Medxy AIen2026-05-12T16:24:56-07:00Why the cTnI/cTnT Ratio May Matter: A New Signal for Distinguishing Acute Necrotic From Chronic Myocardial Injury https://news.medxy.ai/sacubitril-valsartan-improved-exercise-pulmonary-hemodynamics-and-dynamic-atrial-functional-mitral-regurgitation-in-hfpef-interpreting-the-praise-mr-randomized-trial/Medxy AIen2026-05-12T16:10:23-07:00Sacubitril/Valsartan Improved Exercise Pulmonary Hemodynamics and Dynamic Atrial Functional Mitral Regurgitation in HFpEF: Interpreting the PRAISE-MR Randomized Trial https://news.medxy.ai/vi/ty-le-dieu-tri-toan-than-cho-ung-thu-phoi-khong-phai-te-bao-nho-di-can-o-nguoi-cao-tuoi/Medxy AIvi2026-05-12T15:37:49-07:00Tỷ lệ điều trị toàn thân cho ung thư phổi không phải tế bào nhỏ di căn ở người cao tuổi https://news.medxy.ai/ja/%e9%ab%98%e9%bd%a2%e8%80%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%bb%a2%e7%a7%bb%e6%80%a7%e9%9d%9e%e5%b0%8f%e7%b4%b0%e8%83%9e%e8%82%ba%e3%81%8c%e3%82%93%e3%81%ae%e5%85%a8%e8%ba%ab%e6%b2%bb%e7%99%82/Medxy AIja2026-05-12T15:36:06-07:00高齢者における転移性非小細胞肺がんの全身治療の実施率 https://news.medxy.ai/zh/%e8%80%81%e5%b9%b4%e8%bd%ac%e7%a7%bb%e6%80%a7%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e6%82%a3%e8%80%85%e6%8e%a5%e5%8f%97%e7%b3%bb%e7%bb%9f%e6%b2%bb%e7%96%97%e7%9a%84%e6%af%94%e4%be%8b/Medxy AIzh2026-05-12T15:34:29-07:00老年转移性非小细胞肺癌患者接受系统治疗的比例 https://news.medxy.ai/rates-of-systemic-treatment-for-metastatic-non-small-cell-lung-cancer-among-older-adults/Medxy AIen2026-05-12T15:32:44-07:00Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults https://news.medxy.ai/systemic-treatment-remains-underused-in-older-adults-with-metastatic-non-small-cell-lung-cancer/Medxy AIen2026-05-12T15:17:42-07:00Systemic Treatment Remains Underused in Older Adults With Metastatic Non-Small Cell Lung Cancer https://news.medxy.ai/zh/%e9%a2%84%e6%b5%8b%e4%bd%93%e9%87%8d%e5%af%b9%e8%ae%b8%e5%a4%9a%e5%8d%b1%e9%87%8d%e5%a5%b3%e6%80%a7%e5%8f%af%e8%83%bd%e8%bf%87%e9%ab%98%ef%bc%9a%e6%96%b0%e8%af%81%e6%8d%ae%e6%8c%91%e6%88%98%e8%82%ba/Medxy AIzh2026-05-12T13:42:41-07:00预测体重对许多危重女性可能过高：新证据挑战肺保护性通气的核心假设 https://news.medxy.ai/ja/%e4%ba%88%e6%b8%ac%e4%bd%93%e9%87%8d%e3%81%af%e5%a4%9a%e3%81%8f%e3%81%ae%e9%87%8d%e7%af%a4%e3%81%aa%e5%a5%b3%e6%80%a7%e6%82%a3%e8%80%85%e3%81%ab%e3%81%a8%e3%81%a3%e3%81%a6%e9%ab%98%e3%81%99%e3%81%8e/Medxy AIja2026-05-12T13:40:16-07:00予測体重は多くの重篤な女性患者にとって高すぎる可能性がある：肺保護換気の基本的な仮定に新たな証拠が挑戦 https://news.medxy.ai/vi/can-nang-co-the-du-doan-co-the-qua-cao-doi-voi-nhieu-phu-nu-bi-benh-nang-bang-chung-moi-thach-thuc-mot-gia-dinh-cot-loi-trong-thong-khi-bao-ve-phoi/Medxy AIvi2026-05-12T13:37:31-07:00Cân nặng cơ thể dự đoán có thể quá cao đối với nhiều phụ nữ bị bệnh nặng: Bằng chứng mới thách thức một giả định cốt lõi trong thông khí bảo vệ phổi https://news.medxy.ai/predicted-body-weight-may-be-too-high-for-many-critically-ill-women-new-evidence-challenges-a-core-assumption-in-lung-protective-ventilation/Medxy AIen2026-05-12T13:32:50-07:00Predicted Body Weight May Be Too High for Many Critically Ill Women: New Evidence Challenges a Core Assumption in Lung-Protective Ventilation https://news.medxy.ai/zh/%e4%bc%8a%e7%bb%b4%e8%8f%8c%e7%b4%a0%e7%94%a8%e4%ba%8ecovid-19%ef%bc%9a%e4%bb%8e%e5%a4%a7%e6%b5%81%e8%a1%8c%e4%ba%89%e8%ae%ae%e5%88%b0remap-cap%e5%92%8c%e5%85%a8%e7%90%83%e9%9a%8f%e6%9c%ba%e8%af%95/Medxy AIzh2026-05-12T12:16:42-07:00伊维菌素用于COVID-19：从大流行争议到REMAP-CAP和全球随机试验中的明确无效 https://news.medxy.ai/ja/%e3%82%a4%e3%83%99%e3%83%ab%e3%83%a1%e3%82%af%e3%83%81%e3%83%b3%e3%81%a8covid-19%ef%bc%9a%e3%83%91%e3%83%b3%e3%83%87%e3%83%9f%e3%83%83%e3%82%af%e3%81%ae%e8%ab%96%e4%ba%89%e3%81%8b%e3%82%89remap-cap/Medxy AIja2026-05-12T12:15:37-07:00イベルメクチンとCOVID-19：パンデミックの論争からREMAP-CAPおよび世界的大規模無作為試験における決定的な無効性へ https://news.medxy.ai/vi/ivermectin-cho-covid-19-tu-su-bat-dong-trong-dai-dich-den-that-bai-quyet-dinh-trong-cac-thu-nghiem-ngau-nhien-toan-cau-remap-cap/Medxy AIvi2026-05-12T12:14:09-07:00Ivermectin cho COVID-19: Từ Sự Bất Đồng Trong Đại Dịch đến Thất Bại Quyết Định trong Các Thử Nghiệm Ngẫu Nhiên Toàn Cầu REMAP-CAP https://news.medxy.ai/ivermectin-for-covid-19-from-pandemic-controversy-to-definitive-futility-in-the-remap-cap-and-global-randomized-trials/Medxy AIen2026-05-12T12:11:37-07:00Ivermectin for COVID-19: From Pandemic Controversy to Definitive Futility in the REMAP-CAP and Global Randomized Trials https://news.medxy.ai/obesity-counseling-is-still-missed-in-most-us-office-visits-with-older-adults-least-likely-to-receive-advice/Medxy AIen2026-05-12T10:17:36-07:00Obesity Counseling Is Still Missed in Most US Office Visits, With Older Adults Least Likely to Receive Advice https://news.medxy.ai/extended-release-vs-sublingual-buprenorphine-in-pregnancy-through-12-months-post-partum-a-randomized-clinical-trial/Medxy AIen2026-05-11T20:09:29-07:00Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial https://news.medxy.ai/vi/khoi-dau-duoc-pham-cho-roi-loan-su-dung-ruou-trong-cuu-chien-binh-nhap-vien-mot-nghien-cuu-doi-ngu-quay-lai/Medxy AIvi2026-05-11T20:02:23-07:00Khởi đầu Dược phẩm cho Rối loạn Sử dụng Rượu trong Cựu chiến binh Nhập viện: Một Nghiên cứu Đội Ngũ Quay Lại https://news.medxy.ai/ja/%e3%82%a2%e3%83%ab%e3%82%b3%e3%83%bc%e3%83%ab%e4%bd%bf%e7%94%a8%e9%9a%9c%e5%ae%b3%e3%81%ae%e6%b2%bb%e7%99%82%e8%96%ac%e6%8a%95%e4%b8%8e%e9%96%8b%e5%a7%8b%e3%81%ab%e3%81%a4%e3%81%84%e3%81%a6%e3%81%ae/Medxy AIja2026-05-11T20:01:20-07:00アルコール使用障害の治療薬投与開始についての入院退役軍人: 回顧的コホート研究 https://news.medxy.ai/zh/%e4%bd%8f%e9%99%a2%e9%80%80%e4%bc%8d%e5%86%9b%e4%ba%ba%e9%85%92%e7%b2%be%e4%bd%bf%e7%94%a8%e9%9a%9c%e7%a2%8d%e8%8d%af%e7%89%a9%e6%b2%bb%e7%96%97%e7%9a%84%e5%90%af%e5%8a%a8%ef%bc%9a%e4%b8%80%e9%a1%b9/Medxy AIzh2026-05-11T20:00:15-07:00住院退伍军人酒精使用障碍药物治疗的启动：一项回顾性队列研究 https://news.medxy.ai/initiation-of-medications-for-alcohol-use-disorder-among-hospitalized-veterans-a-retrospective-cohort-study/Medxy AIen2026-05-11T19:56:47-07:00Initiation of Medications for Alcohol Use Disorder Among Hospitalized Veterans : A Retrospective Cohort Study https://news.medxy.ai/molecular-profiling-refines-relapse-risk-after-allogeneic-transplant-in-first-remission-acute-myeloid-leukemia/Medxy AIen2026-05-11T19:52:49-07:00Molecular Profiling Refines Relapse Risk After Allogeneic Transplant in First-Remission Acute Myeloid Leukemia https://news.medxy.ai/a-new-ctcl-specific-quality-of-life-tool-shows-strong-early-validity-signals-in-cutaneous-t-cell-lymphoma/Medxy AIen2026-05-11T17:21:00-07:00A New CTCL-Specific Quality-of-Life Tool Shows Strong Early Validity Signals in Cutaneous T-Cell Lymphoma https://news.medxy.ai/vi/lieu-phap-te-bao-t-car-nham-muc-tieu-cd117-cho-thay-hua-hen-chong-lai-mastocytosis-he-thong-tien-trien-trong-cac-nghien-cuu-tien-lam-sang/Medxy AIvi2026-05-11T17:04:27-07:00Liệu pháp tế bào T CAR nhắm mục tiêu CD117 cho thấy hứa hẹn chống lại Mastocytosis hệ thống tiến triển trong các nghiên cứu tiền lâm sàng https://news.medxy.ai/ja/cd117%e3%82%92%e6%a8%99%e7%9a%84%e3%81%a8%e3%81%99%e3%82%8bcar-t%e7%b4%b0%e8%83%9e%e7%99%82%e6%b3%95%e3%80%81%e5%89%8d%e8%87%a8%e5%ba%8a%e7%a0%94%e7%a9%b6%e3%81%a7%e9%80%b2%e8%a1%8c%e6%80%a7%e5%85%a8/Medxy AIja2026-05-11T17:03:05-07:00CD117を標的とするCAR T細胞療法、前臨床研究で進行性全身性マスト細胞症に対する有望な効果を示す https://news.medxy.ai/zh/%e9%9d%b6%e5%90%91cd117%e7%9a%84car-t%e7%bb%86%e8%83%9e%e7%96%97%e6%b3%95%e5%9c%a8%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6%e4%b8%ad%e5%af%b9%e6%99%9a%e6%9c%9f%e7%b3%bb%e7%bb%9f%e6%80%a7%e8%82%a5/Medxy AIzh2026-05-11T17:02:10-07:00靶向CD117的CAR T细胞疗法在临床前研究中对晚期系统性肥大细胞增多症显示前景 https://news.medxy.ai/vi/nghien-cuu-cho-thay-thoi-gian-truyen-khong-anh-huong-den-ket-qua-dieu-tri-bang-lieu-phap-te-bao-t-car-cho-lymphoma-te-bao-b-lon/Medxy AIvi2026-05-11T17:01:54-07:00Nghiên cứu cho thấy thời gian truyền không ảnh hưởng đến kết quả điều trị bằng liệu pháp tế bào T CAR cho lymphoma tế bào B lớn https://news.medxy.ai/zh/%e7%a0%94%e7%a9%b6%e5%8f%91%e7%8e%b0%e8%be%93%e6%b3%a8%e6%97%b6%e9%97%b4%e4%b8%8d%e5%bd%b1%e5%93%8d%e5%a4%a7b%e7%bb%86%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9a%84car-t%e7%bb%86%e8%83%9e%e6%b2%bb-2/Medxy AIzh2026-05-11T17:01:10-07:00研究发现输注时间不影响大B细胞淋巴瘤的CAR T细胞治疗效果 https://news.medxy.ai/car-t-cell-therapy-targeting-cd117-shows-promise-against-advanced-systemic-mastocytosis-in-preclinical-studies/Medxy AIen2026-05-11T17:00:26-07:00CAR T-Cell Therapy Targeting CD117 Shows Promise Against Advanced Systemic Mastocytosis in Preclinical Studies https://news.medxy.ai/study-finds-infusion-timing-does-not-affect-car-t-cell-therapy-outcomes-for-large-b-cell-lymphoma/Medxy AIen2026-05-11T16:58:53-07:00Study Finds Infusion Timing Does Not Affect CAR T-Cell Therapy Outcomes for Large B-Cell Lymphoma https://news.medxy.ai/vi/quan-diem-cua-ban-khoa-hoc-gold-ve-con-bung-phat-va-nguy-co-tim-mach-trong-copd/Medxy AIvi2026-05-11T16:58:16-07:00Quan điểm của Ban Khoa học GOLD về cơn bùng phát và nguy cơ tim mạch trong COPD https://news.medxy.ai/zh/gold%e7%a7%91%e5%ad%a6%e5%a7%94%e5%91%98%e4%bc%9a%e5%85%b3%e4%ba%8ecopd%e5%8a%a0%e9%87%8d%e4%b8%8e%e5%bf%83%e8%a1%80%e7%ae%a1%e9%a3%8e%e9%99%a9%e7%9a%84%e8%a7%82%e7%82%b9/Medxy AIzh2026-05-11T16:57:24-07:00GOLD科学委员会关于COPD加重与心血管风险的观点 https://news.medxy.ai/ja/copd%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a5%e6%80%a7%e5%a2%97%e6%82%aa%e3%81%a8%e5%bf%83%e8%a1%80%e7%ae%a1%e3%83%aa%e3%82%b9%e3%82%af%e3%81%ab%e9%96%a2%e3%81%99%e3%82%8bgold%e7%a7%91%e5%ad%a6/Medxy AIja2026-05-11T16:56:48-07:00COPDにおける急性増悪と心血管リスクに関するGOLD科学委員会の見解 https://news.medxy.ai/a-gold-science-committee-perspective-on-exacerbations-and-cardiovascular-risk-in-copd/Medxy AIen2026-05-11T16:53:33-07:00A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD https://news.medxy.ai/vi/su-tuong-quan-giua-kieu-gen-va-kieu-hinh-trong-loan-duong-vong-mac-lien-quan-den-rpgrip1-o-mot-nhom-benh-nhan-nhat-ban-tren-toan-quoc/Medxy AIvi2026-05-11T16:53:17-07:00Sự tương quan giữa kiểu gen và kiểu hình trong loạn dưỡng võng mạc liên quan đến RPGRIP1 ở một nhóm bệnh nhân Nhật Bản trên toàn quốc https://news.medxy.ai/zh/%e6%97%a5%e6%9c%ac%e5%85%a8%e5%9b%bd%e9%98%9f%e5%88%97%e4%b8%adrpgrip1%e7%9b%b8%e5%85%b3%e8%a7%86%e7%bd%91%e8%86%9c%e8%90%a5%e5%85%bb%e4%b8%8d%e8%89%af%e7%9a%84%e5%9f%ba%e5%9b%a0%e5%9e%8b-%e8%a1%a8/Medxy AIzh2026-05-11T16:52:21-07:00日本全国队列中RPGRIP1相关视网膜营养不良的基因型-表型相关性 https://news.medxy.ai/ja/%e6%97%a5%e6%9c%ac%e5%85%a8%e5%9b%bd%e3%82%b3%e3%83%9b%e3%83%bc%e3%83%88%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8brpgrip1%e9%96%a2%e9%80%a3%e7%b6%b2%e8%86%9c%e5%a4%89%e6%80%a7%e3%81%ae%e3%82%b2%e3%83%8e/Medxy AIja2026-05-11T16:51:30-07:00日本全国コホートにおけるRPGRIP1関連網膜変性のゲノタイプ-フェノタイプ相関 https://news.medxy.ai/genotype-phenotype-correlations-in-rpgrip1-associated-retinal-dystrophy-in-a-nationwide-japanese-cohort/Medxy AIen2026-05-11T16:49:18-07:00Genotype-phenotype correlations in RPGRIP1-associated retinal dystrophy in a nationwide Japanese cohort https://news.medxy.ai/vi/cong-cu-ho-tro-quyet-dinh-ve-amblyopia-dua-tren-web/Medxy AIvi2026-05-11T15:33:11-07:00Công cụ hỗ trợ quyết định về Amblyopia dựa trên web https://news.medxy.ai/ja/%e3%82%a6%e3%82%a7%e3%83%96%e3%83%99%e3%83%bc%e3%82%b9%e3%81%ae%e5%bc%b1%e8%a6%96%e8%a8%ba%e6%96%ad%e6%94%af%e6%8f%b4%e3%83%84%e3%83%bc%e3%83%ab/Medxy AIja2026-05-11T15:32:16-07:00ウェブベースの弱視診断支援ツール https://news.medxy.ai/zh/%e5%9f%ba%e4%ba%8e%e7%bd%91%e7%bb%9c%e7%9a%84%e5%bc%b1%e8%a7%86%e5%86%b3%e7%ad%96%e6%94%af%e6%8c%81%e5%b7%a5%e5%85%b7/Medxy AIzh2026-05-11T15:31:28-07:00基于网络的弱视决策支持工具 https://news.medxy.ai/web-based-amblyopia-decision-support-tool/Medxy AIen2026-05-11T15:29:17-07:00Web-Based Amblyopia Decision Support Tool https://news.medxy.ai/zh/0-05-%e4%b8%99%e9%85%b8%e6%b0%af%e5%80%8d%e4%bb%96%e7%b4%a2%e6%b7%b7%e6%82%ac%e6%bb%b4%e7%9c%bc%e6%b6%b2%ef%bc%9a%e7%99%bd%e5%86%85%e9%9a%9c%e6%9c%af%e5%90%8e%e7%82%8e%e7%97%87%e5%92%8c%e7%96%bc/Medxy AIzh2026-05-11T14:58:41-07:000.05% 丙酸氯倍他索混悬滴眼液：白内障术后炎症和疼痛管理的新里程碑 https://news.medxy.ai/ja/%e3%82%af%e3%83%ad%e3%83%99%e3%82%bf%e3%82%bd%e3%83%bc%e3%83%ab%e3%83%97%e3%83%ad%e3%83%94%e3%82%aa%e3%83%8d%e3%83%bc%e3%83%88%e7%9c%bc%e7%94%a8%e6%87%b8%e6%bf%81%e6%b6%b2-0-05%ef%bc%9a%e7%99%bd/Medxy AIja2026-05-11T14:56:38-07:00クロベタソールプロピオネート眼用懸濁液 0.05%：白内障手術後の炎症と疼痛管理における新しい治療のマイルストーン https://news.medxy.ai/vi/suspensi-ocular-clobetasol-propionate-005-mot-dot-pha-trong-quan-ly-viem-va-dau-sau-phau-thuat-thuy-tinh-the/Medxy AIvi2026-05-11T14:54:00-07:00Suspensi Ocular Clobetasol Propionate 0,05%: Một Đột Phá Trong Quản Lý Viêm và Đau Sau Phẫu Thuật Thủy Tinh Thể https://news.medxy.ai/clobetasol-propionate-ophthalmic-suspension-0-05-a-new-therapeutic-milestone-in-post-cataract-surgery-inflammation-and-pain-management/Medxy AIen2026-05-11T14:49:55-07:00Clobetasol Propionate Ophthalmic Suspension 0.05%: A New Therapeutic Milestone in Post-Cataract Surgery Inflammation and Pain Management https://news.medxy.ai/a-cbt-based-mobile-app-significantly-reduced-tinnitus-distress-in-a-sham-controlled-randomized-trial/Medxy AIen2026-05-11T14:34:53-07:00A CBT-Based Mobile App Significantly Reduced Tinnitus Distress in a Sham-Controlled Randomized Trial